All News about Exelixis Inc
![](https://mms.businesswire.com/media/20230124006010/en/1679909/5/Exelixis_Logo_RGB_2023.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/01/20/exelixis_id_rgb_2c.jpg?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20230119005934/en/1691352/22/Exelixis_Logo_RGB_2023.jpg)
Exelixis Announces Update on Patent Litigation with MSN Laboratories
January 19, 2023
From Exelixis, Inc.
Via Business Wire
![](https://investorplace.com/wp-content/uploads/2022/10/biotechnology1600.png)
6 Analysts Have This to Say About Exelixis
January 11, 2023
Via Benzinga
![](https://g.foolcdn.com/editorial/images/714267/doctor-holding-elderly-patients-hand.jpg)
What 5 Analyst Ratings Have To Say About Exelixis
December 09, 2022
Via Benzinga
![](https://mms.businesswire.com/media/20230108005042/en/1679908/5/Exelixis_Logo_RGB_2023.jpg)
![](https://www.marketbeat.com/logos/articles/small_stock-image_317419908_S.jpg)
![](https://mms.businesswire.com/media/20230103005704/en/610803/5/exelixis_id_rgb_2c.jpg)
![](https://g.foolcdn.com/editorial/images/713916/gettyimages-1285551846.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_30578.jpeg?width=1200&height=800&fit=crop)
Where Exelixis Stands With Analysts
December 09, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_29092.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/11/02/aapharma_4.png?width=1200&height=800&fit=crop)
Exelixis Inks Two Licensing Pacts For Cancer Programs
November 02, 2022
Via Benzinga
![](https://mms.businesswire.com/media/20221221005589/en/611316/5/Exelixis_Logo_JPG.jpg)
![](https://g.foolcdn.com/editorial/images/713434/an-advisor-showing-a-tablet-to-a-couple.jpg)
![](https://g.foolcdn.com/editorial/images/712973/lab-technician-with-clipboard-and-test-tube-getty.jpg)
![](https://g.foolcdn.com/editorial/images/712062/bear-market-stocks-plunge-crash-invest-correction-getty.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/12/09/logo_dark__c424d3ab0271f3cf1e0eea9f187b0781.png?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20221208005867/en/611316/5/Exelixis_Logo_JPG.jpg)
![](https://mms.businesswire.com/media/20221207005626/en/611316/5/Exelixis_Logo_JPG.jpg)
![](https://g.foolcdn.com/editorial/images/711408/cheering-person-with-laptop.jpg)
3 Stocks to Buy Hand Over Fist in December
December 03, 2022
Via The Motley Fool
![](https://mms.businesswire.com/media/20221130005992/en/610803/5/exelixis_id_rgb_2c.jpg)
![](https://g.foolcdn.com/editorial/images/710854/stock-market-chart-crash-correction-buy-investment-planning-laptop-getty.jpg)
![](https://g.foolcdn.com/editorial/images/709244/twenty-dollar-bill-invest-close-up-andrew-jackson-retire-cash-money-getty.jpg)
![](https://g.foolcdn.com/editorial/images/708492/gettyimages-1151223270.jpg)
![](https://mms.businesswire.com/media/20221110006021/en/610803/5/exelixis_id_rgb_2c.jpg)
From Exelixis, Inc.
Via Business Wire
![](https://g.foolcdn.com/editorial/images/708138/nurse-is-listening-with-a-stethoscope-a-patients-chest.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/roce_image_3457.jpeg?width=1200&height=800&fit=crop)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.